EAGLE PHARMACEUTICALS, INC.
EGRX$413M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaWOODCLIFF LAKE
Drugs in Pipeline
4
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
EGRX News
Catalyst Timeline
0 upcoming, 1 past
No catalysts found.
Drug Pipeline
Ryanodex and Standard of Care
Exertional Heat Stroke
CAL02
Pneumonia, Bacterial
Dantrolene sodium for injectable suspension
Heat Stroke
SeeMore(TM)
Myocardial Infarction
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Ryanodex and Standard of Care | Phase 3 | Exertional Heat Stroke | - | - |
CAL02 | Phase 2 | Pneumonia, Bacterial | - | - |
Dantrolene sodium for injectable suspension | Phase 2 | Heat Stroke | - | - |
SeeMore(TM) | Phase 2 | Myocardial Infarction | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply